Global /Switzerland /Healthcare /Drug Manufacturers - Specialty & Generic /CURN
chevron_leftBack

CURATIS N

CURN
SIX: CURN Delayed
10.70CHF 3.9%
12.89 USD
As of 24 April 2025, CURATIS N has a market cap of $62.24M USD, ranking #23632 globally and #210 in Switzerland. It ranks #2379 in the Healthcare sector, and #523 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
23632
Country Rank
210
Sector Rank
2379
Industry Rank
523
Key Stats
Market Cap
$62.24MUSD
51.4M CHF
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.9% 1.9% -7.8% -18% 11% -11%

Markets

Exchange Ticker Price
SIX Swiss Exchange
MIC: XSWX
PRIMARY
CURN
Curatis Holding AG
ISIN: CH1330780979
Shares Out.:
4.986M1 Shares Float: 606.571K2
TV:
SA:
YF:
GF:
BA:
MS:
10.70 CHF
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Switzerland)
Name
Market Cap diff.
Galderma Group AG
GALD
$23.17B
19.13B CHF
37K%
Sandoz Group AG
SDZ
$17.35B
14.33B CHF
28K%
Siegfried Holding AG
SFZN
$4.85B
4.01B CHF
8K%
PolyPeptide Group AG
PPGN
$694.37M
573.48M CHF
1K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
108K%
Merck KGaA
MRK
$59.67B
52.43B EUR
96K%
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
79K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
74K%
Haleon plc
HLN
$45.68B
34.34B GBP
73K%